Clinical Trial Update: Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF) [NA]

View source ↗

Summary

A clinical trial update shows recruitment for a mobile app intended to improve adherence to rivaroxaban in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Atrial Fibrillation | NA | Status: RECRUITING